Saint Joseph's Translational Research Institute

	Jaipal Singh, Ph.D., will join SJTRI as Chief Scientific Officer. Dr. Singh was most recently with Eli Lilly and Company, where he served as head of vascular therapeutics research and research advisor for the Atherosclerosis-Metabolic drug hunting team. Read More
	Saint Joseph’s Translational Research Institute Opens State-Of-The-Art, 32,000-Square-Foot Preclinical Research Facility in the Heart of Atlanta. Read More

Saint Joseph’s Translational Research Institute is a private, nonprofit research institute that combines the efficiencies of a commercial contract research organization with the resources of an academic institution.

While academically focused, SJTRI understands the end goal of bringing devices and therapies to market, which is why half of the SJTRI employees have experience in private industry. SJTRI offers preclinical and clinical resources, regulatory support, collaborative funding opportunities and physician education and training.

To learn more about our Institute, please contact us at (678) 843-6500 or SJTRIresearch@che.org.

ACRI

Media Room | Mission | Privacy Policy | Disclaimer | Site Map

Saint Joseph's Translational Research Institute
5673 Peachtree Dunwoody Road, N.E. • Suite 675 • Atlanta, Georgia 30342
Phone: (678) 843-6500 • E-mail: SJTRIresearch@che.org